Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email